Stock Traders Purchase High Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the target of some unusual options trading activity on Wednesday. Stock investors bought 1,885 put options on the company. This represents an increase of 1,101% compared to the average daily volume of 157 put options.

Evelo Biosciences Stock Performance

NASDAQ:EVLO opened at $0.00 on Thursday. Evelo Biosciences has a twelve month low of $0.00 and a twelve month high of $0.50. The company has a market cap of $7,592.00, a P/E ratio of 0.00 and a beta of 1.29. The company’s 50-day moving average price is $0.01 and its 200-day moving average price is $0.03.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.